Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,750.00
(
-1.58%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
106.58
(
5.89%
)
Bitcoin
71,116.60
(
-3.82%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ThomasS

Send PM Follow Ignore
Followers 12
Posts 2277
Boards Moderated 0
Alias Born 05/05/2005

ThomasS

Re: Rocky3 post# 103644

Tuesday, 09/07/2010 6:44:29 PM

Tuesday, September 07, 2010 6:44:29 PM

Post# of 257257
MNTA: Thanks, Rocky. Interpolated, (with the facts available) infers @ 38% penetration for m-enoxaparin at 27 August. That is quite the sales ramp at 34 days post-approval.

So much for my Copaxone SJ hopes, unless we get surprised with an Inequitable conduct judgement...

"If we don't succeed, we run the risk of failure."
-Dan Quayle

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now